comparemela.com

Ipsen Stock Exchange News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ipsen : delivers strong sales growth for the first nine months and improves its full-year guidance

Paris , 21 October 2021 - Ipsen , a global specialty-driven biopharmaceutical group, publishes its sales performance for the third quarter of 2021 and the year to date. Sales. | June 16, 2023

France generalUnited statesUnited kingdomFanny allaireIpsen euronextDavid loewGwenan whiteDrug administrationPublic affairsGlobal communicationsEuropean medicines agencySpecialty careChief executive officerAccent therapeuticsNucleic acidsSpherical nucleic acids

Ipsen announces U S FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma

Supplemental New Drug Application submission based on the NAPOLI 3 Phase III trial1Approval would represent expansion of treatment options in an aggressive and difficult-to-treat cancer with few. | June 14, 2023

San franciscoUnited statesT ai peiFrance generalUnited kingdomIpsen euronextHoward mayerElizabeth kalinaCommunications patient advocacyDrug administrationGlobal head of franchise communicationsHead of researchSupplemental new drug applicationExecutive vice presidentPrescription drug user fee actIpsen fast track

Correction: Ipsen announces U S FDA submission acceptance of its supplemental New Drug Application for Onivyde regimen in first-line metastatic pancreatic ductal adenocarcinoma

Supplemental New Drug Application submission based on the NAPOLI 3 Phase III trial1Approval would represent expansion of treatment options in an aggressive and difficult-to-treat cancer with few. | June 14, 2023

United statesFrance generalUnited kingdomT ai peiSan franciscoIpsen euronextElizabeth kalinaHoward mayerGlobal head of franchise communicationsDrug administrationHead of researchCommunications patient advocacySupplemental new drug applicationExecutive vice presidentPrescription drug user fee actIpsen fast track

Ipsen : Good timing to go long again | MarketScreener

Ipsen shares are closing back in on major support levels around 106.8 EUR based on daily price data, which could offer attractive entry points. | June 1, 2023

Ipsen stock exchangePress releaseNtry ipn fr0010259150

Ipsen - Description of the regulatory framework of the share repurchase program to be approved at the Combined Shareholders Meeting on 31 May 2023

REGULATED INFORMATION Description of the regulatory framework of the share repurchase programproposed by the Board of Directors to be approved at theCombined Shareholders’ Meeting. | May 31, 2023

France generalUnited statesUnited kingdomAmy wolfNicolas boglerCompany or groupEuropean parliamentBoardof directorsShareholder meetingFrench commercial codeEuropean regulationGeneral regulationFrench autoritDes marchCombined shareholder meetingExtraordinary shareholder

vimarsana © 2020. All Rights Reserved.